SeaCrest Wealth Management LLC Increases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

SeaCrest Wealth Management LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 18,478 shares of the company’s stock after acquiring an additional 2,057 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $1,416,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in GEHC. BlackRock Inc. purchased a new stake in shares of GE HealthCare Technologies during the second quarter valued at $2,334,660,000. State Street Corp acquired a new position in shares of GE HealthCare Technologies in the second quarter valued at about $1,532,290,000. Vanguard Group Inc. lifted its holdings in shares of GE HealthCare Technologies by 14.7% during the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock worth $3,029,917,000 after purchasing an additional 5,693,244 shares during the period. Nuveen Asset Management LLC purchased a new stake in GE HealthCare Technologies in the second quarter valued at approximately $112,365,000. Finally, Trian Fund Management L.P. acquired a new position in GE HealthCare Technologies in the 2nd quarter worth approximately $109,092,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC traded up $0.60 during trading hours on Thursday, hitting $90.91. 2,108,042 shares of the company’s stock traded hands, compared to its average volume of 3,617,774. The company has a market capitalization of $41.40 billion, a PE ratio of 30.12, a PEG ratio of 3.10 and a beta of 0.97. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The firm’s 50-day moving average is $84.70 and its 200-day moving average is $75.39.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same period in the prior year, the business earned $1.31 earnings per share. The business’s revenue was up 5.3% compared to the same quarter last year. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.13%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is currently 3.97%.

Analysts Set New Price Targets

GEHC has been the topic of several recent research reports. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their price objective for the company from $66.00 to $88.00 in a report on Monday, February 12th. Jefferies Financial Group assumed coverage on GE HealthCare Technologies in a research report on Thursday, November 30th. They set a “hold” rating and a $80.00 target price on the stock. Mizuho upped their price target on GE HealthCare Technologies from $94.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Morgan Stanley raised their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Finally, HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 target price for the company. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $88.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.